Needs Assessment

Vascular disease is a leading cause of disability and death in patients over age 50. Nonvascular intervention, especially in oncology patients, continues to increase in most busy practices. As such, there is a critical need for physicians who manage these patients to receive CME in this area. To address this need, the AIMsymposium™ will review the latest pharmacologic, radiologic, surgical and endovascular techniques and technologies as well as discuss when these treatments are justified and indicated and when they are not. Updates on clinical trials and opportunities for dialogue with experts in the field will provide insight, along with the latest data on the results of the various treatment modalities.

Symposium Format

The Advanced Interventional Management Symposium AIMsymposium™ will be held Wednesday - Friday, November 18 - 20, 2009. The scientific sessions, mini-courses, panel discussions and case presentations, presented by a nationally renowned faculty, will provide a concise overview of the most current issues and hands-on experience in new techniques in percutaneous, endovascular and surgical treatment methods. Highlights of the meeting will include hands-on workshops, didactic workshops, cases and joint sessions with the 36th VEITHsymposium™. There will be special emphasis on vascular imaging, neurointervention, fibroid management, aortic stent grafts, hemodialysis access and venous interventions.

Symposium Objectives

1. To acquire new knowledge in the diagnosis and treatment of peripheral vascular disease.

2. To be able to diagnose and treat abdominal aortic aneurysms in a minimally invasive manner.

3. To be able to diagnose and treat various types of tumors with embolic agents and radiofrequency ablation using imaging.

4. To review the normal anatomy and the pathology of veins in the lower extremities.

5. To apply new knowledge of carotid stenting techniques to the participant’s practice.

6. To describe the various methods of maintaining vascular access in the dialysis patient.

Target Audience

Interventional Radiologists, Vascular Surgeons, Interventional Cardiologists, Interventional Nephrologists.

Accreditation Statement

This activity has been approved for AMA PRA Category 1 Credits™.